Security Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,489
Closed -$381K 224
2025
Q4
$381K Sell
7,489
-516
-6% -$26.4K 0.06% 158
2025
Q3
$444K Buy
8,005
+1,790
+29% +$105K 0.07% 134
2025
Q2
$429K Buy
6,215
+1,212
+24% +$82.4K 0.08% 126
2025
Q1
$347K Buy
5,003
+1,631
+48% +$135K 0.07% 129
2024
Q4
$290K Buy
3,372
+159
+5% +$17.2K 0.06% 139
2024
Q3
$383K Buy
3,213
+146
+5% +$19.5K 0.08% 111
2024
Q2
$438K Sell
3,067
-7
-0.2% -$928 0.1% 107
2024
Q1
$395K Buy
3,074
+695
+29% +$82.7K 0.09% 116
2023
Q4
$246K Buy
2,379
+28
+1% +$2.77K 0.06% 148
2023
Q3
$214K Sell
2,351
-161
-6% -$14.2K 0.06% 153
2023
Q2
$203K Sell
2,512
-592
-19% -$48.4K 0.06% 149
2023
Q1
$247K Buy
+3,104
New +$220K 0.08% 125

Other funds holding NVO

Security Financial Services's NVO Position: Q1 2026 in Review

Security Financial Services sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 7,489 shares — an estimated $381K sold.

Security Financial Services first reported a position in NVO in Q1 2023 and held it in 12 quarters. The position peaked at $444K in Q3 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Security Financial Services reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Security Financial Services sold 7,489 Novo Nordisk shares in Q1 2026, an estimated $381K.
  • Security Financial Services first reported a position in Novo Nordisk in Q1 2023 and held it in 12 quarters.
  • Security Financial Services's Novo Nordisk position peaked at $444K in Q3 2025.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Security Financial Services's 13F filing for Q1 2026, filed 27 May 2026.